These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 34722189)

  • 21. Loco-regional therapies for patients with hepatocellular carcinoma awaiting liver transplantation: Selecting an optimal therapy.
    Byrne TJ; Rakela J
    World J Transplant; 2016 Jun; 6(2):306-13. PubMed ID: 27358775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver Transplantation for Advanced Hepatocellular Carcinoma after Downstaging Without Up-Front Stage Restrictions.
    Chapman WC; Garcia-Aroz S; Vachharajani N; Fowler K; Saad N; Lin Y; Wellen J; Tan B; Khan AS; Doyle MB
    J Am Coll Surg; 2017 Apr; 224(4):610-621. PubMed ID: 28069527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Doxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation.
    Nicolini D; Svegliati-Baroni G; Candelari R; Mincarelli C; Mandolesi A; Bearzi I; Mocchegiani F; Vecchi A; Montalti R; Benedetti A; Risaliti A; Vivarelli M
    World J Gastroenterol; 2013 Sep; 19(34):5622-32. PubMed ID: 24039354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bridging and downstaging therapy in patients suffering from hepatocellular carcinoma waiting on the list of liver transplantation.
    She WH; Cheung TT
    Transl Gastroenterol Hepatol; 2016; 1():34. PubMed ID: 28138601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downstaging hepatocellular carcinoma: A systematic review and pooled analysis.
    Parikh ND; Waljee AK; Singal AG
    Liver Transpl; 2015 Sep; 21(9):1142-52. PubMed ID: 25981135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver Transplantation Update: 2014.
    Dogan S; Gurakar A
    Euroasian J Hepatogastroenterol; 2015; 5(2):98-106. PubMed ID: 29201702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver transplantation for hepatocellular carcinoma: outcomes and treatment options for recurrence.
    Rahimi RS; Trotter JF
    Ann Gastroenterol; 2015; 28(3):323-330. PubMed ID: 26130250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience.
    Lee KW; Yi NJ; Suh KS
    Transplantation; 2014 Apr; 97 Suppl 8():S20-3. PubMed ID: 24849825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Living donor liver transplantation for hepatocellular carcinoma achieves better outcomes.
    Lin CC; Chen CL
    Hepatobiliary Surg Nutr; 2016 Oct; 5(5):415-421. PubMed ID: 27826556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: A review.
    Xu DW; Wan P; Xia Q
    World J Gastroenterol; 2016 Mar; 22(12):3325-34. PubMed ID: 27022214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Living donor liver transplantation for hepatocellular cancer: an (almost) exclusive Eastern procedure?
    Pinheiro RS; Waisberg DR; Nacif LS; Rocha-Santos V; Arantes RM; Ducatti L; Martino RB; Lai Q; Andraus W; D'Albuquerque LAC
    Transl Gastroenterol Hepatol; 2017; 2():68. PubMed ID: 28905009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatocellular carcinoma locoregional therapies for patients in the waiting list. Impact on transplantability and recurrence rate.
    Cescon M; Cucchetti A; Ravaioli M; Pinna AD
    J Hepatol; 2013 Mar; 58(3):609-18. PubMed ID: 23041304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver Transplantation in Patients with Hepatocellular Carcinoma beyond the Milan Criteria: A Comprehensive Review.
    Toniutto P; Fumolo E; Fornasiere E; Bitetto D
    J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.
    Abdel-Rahman OM; Elsayed Z
    Cochrane Database Syst Rev; 2016 Feb; 2():CD011313. PubMed ID: 26905230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current controversies surrounding liver transplantation for hepatocellular carcinoma.
    Silva MF; Wigg AJ
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1217-26. PubMed ID: 20594247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison between living donor liver transplantation recipients who met the Milan and UCSF criteria after successful downstaging therapies.
    Lei J; Yan L
    J Gastrointest Surg; 2012 Nov; 16(11):2120-5. PubMed ID: 22948843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bridging patients with hepatocellular cancer waiting for liver transplant: all the patients are the same?
    Coletta M; Nicolini D; Benedetti Cacciaguerra A; Mazzocato S; Rossi R; Vivarelli M
    Transl Gastroenterol Hepatol; 2017; 2():78. PubMed ID: 29034351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current status of therapy for hepatocellular carcinoma.
    Corey KE; Pratt DS
    Therap Adv Gastroenterol; 2009 Jan; 2(1):45-57. PubMed ID: 21180533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatocellular Carcinoma: Downstaging to Liver Transplantation as Curative Therapy.
    Frankul L; Frenette C
    J Clin Transl Hepatol; 2021 Apr; 9(2):220-226. PubMed ID: 34007804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selection of patients with hepatocellular carcinoma for liver transplantation: Past and future.
    Soriano A; Varona A; Gianchandani R; Moneva ME; Arranz J; Gonzalez A; Barrera M
    World J Hepatol; 2016 Jan; 8(1):58-68. PubMed ID: 26783421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.